Bio-Rad and Alleghany Health Network partner for patients with solid tumour cancer
Solid tumour cancers account for 90% of adult human cancers and 50% of childhood malignancies
Read More
Tag: Moonshot
Leukaemia drug shows promise in ovarian cancer
A drug approved for leukaemia has also shown promise in treating a specific type of ovarian cancer in a Cancer Research UK-funded study published in the journal Molecular Cancer Therapeutics.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
